Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Repetitive Transcranial Magnetic Stimulation in the Treatment of Mild Cognitive Impairment Due to Brain Injury

NCT02420522 is registered in ClinicalTrials.gov with University of Manitoba as lead sponsor.

NCT NCT02420522
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02420522 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Repetitive Transcranial Magnetic Stimulation in the Treatment of Mild Cognitive Impairment Due to Brain Injury
Lead sponsor
University of Manitoba
Phase
Not applicable
Overall status
Suspended
Start date
September 30, 2015
Completion date
December 31, 2021
Enrollment
64 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mild cognitive impairment